Celldex Therapeutics (CLDX) Cost of Revenue (2010 - 2026)
Celldex Therapeutics (CLDX) posted quarterly Cost of Revenue of $1.5 million for Q1 2026, down 32.75% year-over-year from $2.2 million in Q1 2025, and up 18.73% quarter-over-quarter from $1.2 million in Q4 2025.
Celldex Therapeutics (CLDX) Cost of Revenue (2010 - 2026) Analysis & Trends
Celldex Therapeutics' Cost of Revenue history runs 7 years deep, the most recent figure standing at $1.5 million for Q1 2026.
- In Q1 2026, Cost of Revenue fell 32.75% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at $5.3 million (down 18.3% YoY), while the FY2025 annual figure was $6.0 million, up 6.88% from the prior year.
- Cost of Revenue for Q1 2026 stood at $1.5 million, up from $1.2 million in the prior quarter.
- The five-year high for Cost of Revenue was $2.2 million in Q1 2025, with the low at $1.1 million in Q3 2025.
- The 3-year median for Cost of Revenue is $1.5 million (2026), against an average of $1.5 million.
- The sharpest annual moves came in 2025 and 2026: Cost of Revenue surged 65.75% in 2025, then tumbled 32.75% in 2026.
- Celldex Therapeutics' Cost of Revenue stood at $1.6 million in 2024, then fell by 23.92% to $1.2 million in 2025, then gained by 18.73% to $1.5 million in 2026.
- Business Quant data shows CLDX's Cost of Revenue at $1.5 million in Q1 2026, $1.2 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 489.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 360.70 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 145.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 174.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1.18 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 298.26 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 67.21 Mn |
| 10 | Celldex Therapeutics | 3.29 Bn | 2.58 Bn | -2.57 Mn | 2.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.59 Mn |
| Jun 30, 2026 | 2.59 Mn |
| Mar 31, 2026 | 1.46 Mn |
| Mar 31, 2026 | 1.46 Mn |
| Dec 31, 2025 | 1.23 Mn |
| Dec 31, 2025 | 1.23 Mn |
| Sep 30, 2025 | 1.06 Mn |
| Sep 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 1.54 Mn |
| Jun 30, 2025 | 1.54 Mn |
| Mar 31, 2025 | 2.17 Mn |
| Mar 31, 2025 | 2.17 Mn |
| Dec 31, 2024 | 1.61 Mn |
| Dec 31, 2024 | 1.61 Mn |
| Sep 30, 2024 | 1.07 Mn |
| Sep 30, 2024 | 1.07 Mn |
| Jun 30, 2024 | 1.62 Mn |
| Jun 30, 2024 | 1.62 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.31 Mn |